34. Rouze A, Cottereau A, Nseir S. Chronic obstructive pulmonary disease and the risk for ventilator‐ associated pneumonia. Curr Opin Crit Care. 2014;20(5):doi:10.1097/MCC.0000000000000123. 35. Luize AP, Menezes AM, Perez‐Padilla R, Muino A, Lopez MV, Valdivia G, et al. Assessment of five different guideline indication criteria for spirometry, including modified GOLD criteria, in order to detect COPD: data from 5,315 subjects in the PLATINO study. NPJ Prim Care Respir Med. 2014;24:doi:10.1038/npjpcrm.2014.75. 36. Funk GC, Bauer P, Burghuber OC, Fazekas A, Hartl S, Hochrieser H, et al. Prevalence and prognosis of COPD in critically ill patients between 1998 and 2008. Eur Respir J. 2013;41(4):doi:10.1183/09031936.00226411. 37. Dubosky MN, Chen YF, Henriksen ME, Vines DL. Vibrating Mesh Nebulizer Compared With Metered‐Dose Inhaler in Mechanically Ventilated Subjects. Respir Care. 2017;62(4):doi:10.4187/respcare.04823. 4 87 Risk factors for VAP using flexible methods
RkJQdWJsaXNoZXIy MTk4NDMw